| 2933.99.97 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,L,MA,MX, P,SG) | 30.5% |
| 2934 | | Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: | | | | |
| 2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.10.20 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.10.70 | 00 | Other: | | | | |
| 2934.10.90 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,L,MA,MX, P,SG) | 30.5% |
| 2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.20.05 | 00 | N-tert-Butyl-2-benzothiazolesulfenamide | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.20.15 | 00 | 2-Mercaptobenzothiazole; and N-(Oxydiethylene)benzothiazole-2-sulfenamide | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.20.20 | 00 | 2-Mercaptobenzothiazole, sodium salt (2-Benzothiazolethiol, sodium salt) | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.8% (SG) | 15.4¡é/kg + 40% |
| 2934.20.35 | 00 | Other: | | | | |
| 2934.20.40 | 00 | Other: | | | | |
| 2934.20.80 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30.23 | 00 | Other: | | | | |
| 2934.30.23 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¡é/kg + 149.5% |
| 2934.30.27 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¡é/kg + 45% |
| 2934.30.43 | 00 | Other: | | | | |
| 2934.30.50 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 52% |
| 2934.91.00 | 00 | Other: | | | | |
| 2934.91.00 | 00 | Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof | kg | Free | | 15.4¡é/kg + 52% |
| 2934.99 | | Other: | | | | |
| 2934.99.03 | 00 | 2-Acetylbenzo(b)thiophene; 3-Methylene-7-(2-phenoxyacetamido)- cephan-4-carboxylic acid, p-nitrobenzyl ester, 1-oxide; and Naphth[1,2-d]-[1,2,3]-oxadiazole-5-sulfonic acid and its sodium salt | kg | Free | | 15.4¡é/kg + 52% |
| 2934.99.11 | 00 | Other: | | | | |
| 2934.99.11 | 00 | 2-tert-Butyl-4-(2,4-dichloro-5- isopropoxyphenyl)- 2-1,3,4- oxadiazolin-5-one; 3-Isopropyl-1H-2,1,3- benzothiadiazin-4-(3H)-one-2,2- dioxide (Bentazon); and O,O-Diethyl-S-[(6-chloro-2- oxobenzoxazolin-3-yl)methyl]¡é/phosphorodithioate (Phosalone) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 40.5% |
